drugset / Trial / NCT00936624

Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent Asthma

NCT00936624

Phase 2 Completed 245 enrolled SK Chemicals Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a dose finding trial to assess the efficacy and safety of SOTB07 in persistent asthma.

Timeline

Start
2009-07
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Montelukast Other / unclassified 10 mg Oral
Subject SOTB07 Unknown 100 mg
Subject SOTB07 Unknown 200 mg

Indications